Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free ALGN Stock Alerts

Align Technology (ALGN) Competitors

Align Technology logo
$150.82 +0.10 (+0.07%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$150.82 0.00 (0.00%)
As of 09/11/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? Align Technology's main competitors and comparable companies include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Align Technology compare to DexCom?

Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B2.68$410.35M$5.7526.23
DexCom$4.66B6.72$836.30M$2.5332.82

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology9.99% 15.86% 10.32%
DexCom 20.12%35.94%14.75%

In the previous week, Align Technology had 2 more articles in the media than DexCom. MarketBeat recorded 14 mentions for Align Technology and 12 mentions for DexCom. Align Technology's average media sentiment score of 1.31 beat DexCom's score of 0.88 indicating that Align Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DexCom
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology presently has a consensus price target of $206.36, indicating a potential upside of 36.82%. DexCom has a consensus price target of $88.71, indicating a potential upside of 6.84%. Given Align Technology's higher possible upside, equities analysts clearly believe Align Technology is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
DexCom
1 Sell rating(s)
2 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.92

Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, DexCom has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market.

88.4% of Align Technology shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.8% of Align Technology shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

DexCom beats Align Technology on 11 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market.

HealthEquity currently has a consensus target price of $111.87, suggesting a potential upside of 16.21%. Align Technology has a consensus target price of $206.36, suggesting a potential upside of 36.82%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.85
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

HealthEquity has a net margin of 17.36% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.36% 15.33% 9.51%
Align Technology 9.99%15.86%10.32%

In the previous week, Align Technology had 6 more articles in the media than HealthEquity. MarketBeat recorded 14 mentions for Align Technology and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.43 beat Align Technology's score of 1.31 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B6.06$215.20M$2.7734.75
Align Technology$4.03B2.68$410.35M$5.7526.23

Summary

HealthEquity and Align Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Henry Schein presently has a consensus target price of $92.93, suggesting a potential upside of 5.18%. Align Technology has a consensus target price of $206.36, suggesting a potential upside of 36.82%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Henry Schein.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.53
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Align Technology has a net margin of 9.99% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein2.96% 15.97% 5.56%
Align Technology 9.99%15.86%10.32%

In the previous week, Align Technology had 9 more articles in the media than Henry Schein. MarketBeat recorded 14 mentions for Align Technology and 5 mentions for Henry Schein. Align Technology's average media sentiment score of 1.31 beat Henry Schein's score of 0.78 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Henry Schein has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$13.18B0.75$398M$3.4325.76
Align Technology$4.03B2.68$410.35M$5.7526.23

Summary

Align Technology beats Henry Schein on 12 of the 17 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Align Technology (NASDAQ:ALGN) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Align Technology presently has a consensus price target of $206.36, indicating a potential upside of 36.82%. Medpace has a consensus price target of $595.20, indicating a potential upside of 1.31%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67
Medpace
0 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

Medpace has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B2.68$410.35M$5.7526.23
Medpace$2.53B6.48$451.12M$17.0634.44

Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 20.5% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology9.99% 15.86% 10.32%
Medpace 17.67%110.15%24.84%

In the previous week, Align Technology had 4 more articles in the media than Medpace. MarketBeat recorded 14 mentions for Align Technology and 10 mentions for Medpace. Medpace's average media sentiment score of 1.63 beat Align Technology's score of 1.31 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
9 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Medpace beats Align Technology on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Quanterix (NASDAQ:QTRX) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Quanterix has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market.

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quanterix$138.90M0.87-$107.15M-$2.63N/A
Align Technology$4.03B2.68$410.35M$5.7526.23

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.5% of Quanterix shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Align Technology had 13 more articles in the media than Quanterix. MarketBeat recorded 14 mentions for Align Technology and 1 mentions for Quanterix. Quanterix's average media sentiment score of 1.87 beat Align Technology's score of 1.31 indicating that Quanterix is being referred to more favorably in the media.

Company Overall Sentiment
Quanterix Very Positive
Align Technology Positive

Align Technology has a net margin of 9.99% compared to Quanterix's net margin of -80.25%. Align Technology's return on equity of 15.86% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Quanterix-80.25% -26.09% -19.03%
Align Technology 9.99%15.86%10.32%

Quanterix presently has a consensus price target of $3.00, suggesting a potential upside of 17.19%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 36.82%. Given Align Technology's stronger consensus rating and higher possible upside, analysts plainly believe Align Technology is more favorable than Quanterix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Align Technology beats Quanterix on 15 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALGN vs. The Competition

Export
MetricAlign TechnologyHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$10.80B$5.48B$7.16B$12.85B
Dividend YieldN/A1.80%2.57%11.71%
P/E Ratio26.2325.09274.9425.33
Price / Sales2.6871.56633.8090.72
Price / Cash12.7033.0328.4234.96
Price / Book2.675.9710.336.21
Net Income$410.35M$150.75M$3.50B$358.54M
7 Day Performance-4.92%-2.83%-3.32%-2.35%
1 Month Performance-14.40%-3.73%-0.53%-3.23%
1 Year Performance14.64%9.38%23.51%8.79%

Align Technology Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALGN
Align Technology
3.9525 of 5 stars		$150.82
+0.1%		$206.36
+36.8%		+14.6%$10.80B$4.03B26.2320,290
DXCM
DexCom
3.4486 of 5 stars		$87.90
flat		$88.71
+0.9%		+8.9%$33.17B$4.66B34.7411,000
HQY
HealthEquity
4.3064 of 5 stars		$96.07
flat		$111.87
+16.4%		+4.1%$7.95B$1.31B34.682,814
HSIC
Henry Schein
2.0987 of 5 stars		$89.81
flat		$92.93
+3.5%		+28.0%$10.01B$13.18B26.1825,000
MEDP
Medpace
2.8074 of 5 stars		$591.29
flat		$595.20
+0.7%		+19.7%$16.50B$2.53B34.666,200

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel